INFER 2NCT06851130
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved 12 months later.
See at-risk trials from Swiss Federal Institute of Technology
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2026
- Eligibility criteria expanded, about 7 words
- Enrollment closed, study ongoing
- Site details revised
- Minor Start date changed from estimate of Feb 27, 2025 to Feb 25, 2025v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Serum ferritin
Timeframe: Study day 31
Secondary (5)
alpha(1)-acid-glycoprotein
Serum ferritin
Serum Ferritin
Hemoglobin
C-reactive protein
Arms and interventions
80 mgExperimental
Daily dose of 80 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total).
160Experimental
Daily dose of 160 mg of iron for 1 month, with a 7-day break, then again for another month (2 months total).
Dietary supplements: ferrous sulfate 80 mg, ferrous sulfate 160 mg
Sites
1 site in 1 country
- Laboratory of Nutrition and Metabolic EpigeneticsZurich, Canton of Zurich, Switzerland